Scholarlink

<p>This study aimed to evaluate the neuroprotective effects of mixed extracts from <i>Dioscorea bulbifera</i> and <i>Zingiber officinale</i> (DBZO) against glutamate-induced excitotoxicity in HT-22 cells and to elucidate the associated molecular mechanisms. Neurotoxicity and protective effects were assessed using MTT and LDH assays, while cellular morphology was analyzed via microscopy. DBZO extract significantly restored axonal integrity disrupted by glutamate exposure. A DCFDA assay confirmed that DBZO reduced reactive oxygen species (ROS) generation in a concentration-dependent manner, underscoring its antioxidant capacity. Western blot analysis demonstrated that DBZO markedly decreased glutamate-induced neuronal death at 0.25 and 0.5&#xa0;mg/mL. The observed neuroprotection was associated with the inhibition of the MAPK signaling cascade and the downregulation of apoptotic markers, including Caspase-3 and PARP. Moreover, DBZO activated the PI3K/Akt/mTOR survival pathway, enhancing neuronal viability. It also boosted antioxidant defenses by modulating Keap1 and NQO1 expression, thereby reducing oxidative damage. Collectively, these findings suggest that DBZO confers neuroprotection by regulating oxidative stress and apoptosis through NRf2/NQO-1 signaling. Due to its strong antioxidant and antiapoptotic properties.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Protective effects of Dioscorea bulbifera and Zingiber officinale mixed extracts against glutamate-induced cell death in HT22 cells

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月14日

查看全文
  • Seung Woo Im,
  • Won Min Jeong,
  • Dong Yeol Lee,
  • Tae Woo Oh

摘要

This study aimed to evaluate the neuroprotective effects of mixed extracts from Dioscorea bulbifera and Zingiber officinale (DBZO) against glutamate-induced excitotoxicity in HT-22 cells and to elucidate the associated molecular mechanisms. Neurotoxicity and protective effects were assessed using MTT and LDH assays, while cellular morphology was analyzed via microscopy. DBZO extract significantly restored axonal integrity disrupted by glutamate exposure. A DCFDA assay confirmed that DBZO reduced reactive oxygen species (ROS) generation in a concentration-dependent manner, underscoring its antioxidant capacity. Western blot analysis demonstrated that DBZO markedly decreased glutamate-induced neuronal death at 0.25 and 0.5 mg/mL. The observed neuroprotection was associated with the inhibition of the MAPK signaling cascade and the downregulation of apoptotic markers, including Caspase-3 and PARP. Moreover, DBZO activated the PI3K/Akt/mTOR survival pathway, enhancing neuronal viability. It also boosted antioxidant defenses by modulating Keap1 and NQO1 expression, thereby reducing oxidative damage. Collectively, these findings suggest that DBZO confers neuroprotection by regulating oxidative stress and apoptosis through NRf2/NQO-1 signaling. Due to its strong antioxidant and antiapoptotic properties.

Graphical Abstract